PALLAS Revenue and Competitors
Estimated Revenue & Valuation
- PALLAS's estimated annual revenue is currently $68.9M per year.
- PALLAS's estimated revenue per employee is $319,000
Employee Data
- PALLAS has 216 Employees.
- PALLAS grew their employee count by 29% last year.
PALLAS's People
Name | Title | Email/Phone |
---|---|---|
1 | Procuremet officer | Reveal Email/Phone |
2 | Configuration Manager | Reveal Email/Phone |
3 | Project Controls Manager | Reveal Email/Phone |
4 | Design Control Manager Nuclear | Reveal Email/Phone |
5 | Data Analyst | Reveal Email/Phone |
6 | Junior Communications Advisor | Reveal Email/Phone |
PALLAS Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $30.7M | 106 | 7% | N/A | N/A |
#2 | $28.4M | 98 | 2% | N/A | N/A |
#3 | $29.3M | 101 | 9% | N/A | N/A |
#4 | $18M | 69 | -14% | N/A | N/A |
#5 | $36.3M | 125 | -11% | N/A | N/A |
#6 | $39.4M | 136 | 1% | N/A | N/A |
#7 | $34.5M | 119 | -6% | N/A | N/A |
#8 | $73.7M | 231 | 4% | N/A | N/A |
#9 | $77.2M | 242 | 38% | N/A | N/A |
#10 | $73.7M | 231 | 8% | N/A | N/A |
What Is PALLAS?
Foundation Preparation Pallas-reactor (PALLAS) is responsible for obtaining a licensable design, obtaining private investors, and constructing and operating the PALLAS-reactor. The new reactor will be one of the most leading reactors in the world: PALLAS will help tens of thousands patients every day by providing medical isotopes. These are the radioactive particles in nuclear medicine that are crucial elements in order to diagnose or treat illnesses such as heart and vascular disease and cancer. PALLAS will also be an important player in (medical) nuclear technological research.
keywords:N/AN/A
Total Funding
216
Number of Employees
$68.9M
Revenue (est)
29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $36M | 226 | 22% | N/A |
#2 | $36.3M | 275 | 6% | N/A |